Sol-Gel Technologies Ltd

NASDAQ:SLGL

0.68

+0.02 (+3.36%)

7:54:04 PM EDT: $0.69 +0.01 (+1.47%)

Market Cap (Intraday)	18.94M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$4.2 Million
Adjusted EPS	-$0.05

See more estimates

10-Day MA	$0.67
50-Day MA	$0.60
200-Day MA	$0.86

See more pivots

Sol-Gel Technologies Ltd Stock, NASDAQ:SLGL

Weizmann Science Park, 7 Golda Meir Street, Ness Ziona, Tel Aviv 74036

Israel

Phone: +972.8.931.3433

Number of Employees: 36

http://www.sol-gel.com

Description

Sol-Gel Technologies Ltd. operates as a clinical-stage dermatology company, which engages in the identification, development, and commercialization of topical dermatological drug products for the treatment of skin diseases. Its products include VERED, TWIN, and SIRS-T. The company was founded by David Avnir and Alon Seri-Levy on October 28, 1997 and is headquartered in Ness Ziona, Israel.